Proactive Investors
26 Jun 2026, 13:53 UTC · 13w ago
Verdict
Headline takes no side. We score EPP +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Scancell Holdings is in advanced discussions for a reverse merger with US-listed Neuphoria Therapeutics to gain a Nasdaq listing.
So whatA Nasdaq listing significantly increases visibility to US institutional capital and typically improves liquidity and valuation for small-cap biotech firms.
More positive than 93% of claims this week
Scancell is pursuing separate equity and debt financing to fund a global phase III registrational study for its lead drug candidate iSCIB1+.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 87% of claims this week
EnergyPathways PLC has launched Front End Engineering and Design (FEED) for a potentially world-leading compressed air energy storage project.
More positive than 66% of claims this week
EnergyPathways has secured a £15 million financing package to fund its pre-FEED work with Siemens Energy.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company has launched FEED for a potentially world-leading energy storage project with confirmed viability and secured financing.
More positive than 76% of ticker scores this week
The company is in advanced discussions for a reverse merger to gain a Nasdaq listing and is seeking funding for a Phase III study.
More positive than 61% of ticker scores this week
Siemens Energy is mentioned as the partner that confirmed the viability of EnergyPathways' project.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
4h ago
+4.2%
Price agrees with the score
$55.31 vs $53.07 close before publication (Jun 25) · not market-adjusted
EPP chart →
